| Adapting a naturally occuring protein cage to modulate an array of therapeutic delivery properties in various disease settings | |  | | 2021 | 545 | 3 |
|
| Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases | Expert Opinion on Drug Delivery | | | 2019 | 306 | 1 |
|
